Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910853 · ClinicalTrials.gov registry record
Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia
A clinical trial, sponsored by Sanguine Biosciences.
- Terminated
- Registry status
- 4
- Enrollment target
NCT05910853 is a clinical trial that was terminated before completion, run by Sanguine Biosciences. The registered enrollment target is 4 participants.
The verdict
NCT05910853 was terminated before completion, sponsored by Sanguine Biosciences.
- TERMINATED
- Registry status
- 4 participants
- Enrollment target
Study Summary
The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Fanconi Anemia. The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling. The disease sample collection and analysis will be the foundation for an extensive network of biospecimen access and linked datasets for future translational research.
Interventions
- DIAGNOSTIC_TEST Specimen Donation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2023-05-24 |
| Est. Completion | 2024-03-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05910853
The ClinicalTrials.gov registry entry for NCT05910853 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanguine Biosciences, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Specimen Donation is the first listed.
NCT05910853 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05910853 about?
NCT05910853 is a clinical study titled "Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia". The primary study objective is to collect biospecimen samples (e.g., blood) from participants diagnosed with Fanconi Anemia. The biospecimens will be used to create a biorepository that can be used to identify disease associated biomarkers and potential targets with immune and multi-omics profiling....
What is the current status of trial NCT05910853?
This trial is currently terminated. The enrollment target is 4 participants. The study started on 2023-05-24. Estimated completion is 2024-03-12.
What interventions are being tested in trial NCT05910853?
The interventions under investigation include: Specimen Donation (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05910853?
This trial is sponsored by Sanguine Biosciences, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.